Total Funding
78
60
Total FundingPost-IPO Equity raised
Growth Score
-6 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
14143
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Susan D. Jones: Chief Technology OfficerPast Role: Harpoon Therapeutics, Senior Vice President, Product Development- Yung Chyung: EVP and CMO
About the Company
Tourmaline Bio develops medicines for inflammatory and immune diseases. The company focuses on creating a pipeline of drug candidates for patients with life-altering conditions. It aims to develop new treatments for areas with high unmet medical needs.
